Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): effects on outcomes at day 365 in a randomised, sham-controlled, blinded, phase III, superiority ambulance-based trial

Background The Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial-2 (RIGHT-2) reported no overall treatment difference between glyceryl trinitrate (GTN) and sham at day 90. Here we assess participants’ outcomes 1 year after randomisation.Methods RIGHT-2 was an ambulance-based p...

Full description

Bibliographic Details
Main Authors: Joanna M Wardlaw, Jeffrey L Saver, Philip M Bath, Thompson G Robinson, Keith Muir, Jason P Appleton, Lisa J Woodhouse, Nikola Sprigg, Marc Randall, Christine Roffe, Else C Sandset, Christopher I Price, Grant Mair, Stuart Pocock, Timothy J England, Aloysius Niroshan Siriwardena, Sandeep Ankolekar
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:BMJ Neurology Open
Online Access:https://neurologyopen.bmj.com/content/5/1/e000424.full

Internet

https://neurologyopen.bmj.com/content/5/1/e000424.full

Similar Items